CSR Analysis Daiichi Sankyo France
daiichi-sankyo.frDevelopment and production of pharmaceuticals in the fields of oncology, onco-hematology, and cardiology.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
Sector data Industrie pharmaceutique et biotechnologies
8,585CSR initiatives analyzed in sector Industrie pharmaceutique et biotechnologies
2,292Companies in sector Industrie pharmaceutique et biotechnologies
1,237SMEs (10 to 250 employees) in sector Industrie pharmaceutique et biotechnologies
+160,000
Total organizations analyzedDiscover our sector reports
Detailed analysis by theme
Analysis by axis
Discover the complete analysis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
How are these scores calculated?
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
They trust us
